Nanox to Report Fourth Quarter 2025 Financial Results on April 20, 2026
Rhea-AI Summary
Nano-X Imaging (Nasdaq: NNOX) will report fourth quarter 2025 financial results before market open on Monday, April 20, 2026. A conference call and live webcast with CEO Erez Meltzer and CFO Ran Daniel begins at 8:30 a.m. ET to review results and provide a business update.
Registration and webcast links will be posted in the Investor Relations Events and Presentations section for interested parties.
Positive
- None.
Negative
- None.
News Market Reaction – NNOX
In the Apr 7 session, NNOX declined 2.95%, reflecting a moderate negative market reaction. Argus tracked a trough of -2.8% from its starting point during tracking. Our momentum scanner triggered 9 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Previous Earnings date Reports
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| Nov 07 | Earnings date notice | Neutral | -1.6% | Set Q3 2025 earnings release and call timing before market open. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Prior earnings-date notice on Nov 7, 2025 saw a modest negative reaction of -1.64%, indicating slightly cautious trading around scheduling updates.
Recent news flow has focused on commercial rollout of Nanox.ARC and, for the matched tag, routine earnings-date scheduling. The prior earnings-date release on Nov 7, 2025 set a call for Nov 20, 2025 at 8:30 a.m. ET and led to a -1.64% move. Today’s Q4 2025 reporting announcement similarly provides timing and access details without disclosing financial metrics.
AI-generated analysis. How Rhea-AI works. Not financial advice.
PETACH TIKVA, Israel, April 06, 2026 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended December 31, 2025, before market open on Monday, April 20, 2026. Erez Meltzer, Chief Executive Officer and Acting Chairman, and Ran Daniel, Chief Financial Officer, will host a conference call to review these results and provide a business update beginning at 8:30 a.m. ET.
Interested parties may register for the conference call using the following link: Nanox Q4 2025 Call
The live webcast of the conference call may be accessed by using the following link: Nanox Q4 2025 Webcast.
The webcast link will also be posted in the Investor Relations section of the Nanox website at Events and Presentations.
About Nanox
Nanox (NASDAQ: NNOX) is focused on driving the world’s transition to preventive health care by delivering an integrated, end-to-end medical imaging and healthcare services platform.
Nanox combines affordable imaging hardware, advanced AI-based solutions, cloud-based software, access to remote radiology, health IT solutions, and a marketplace to enable earlier detection, improved clinical efficiency, and broader access to care.
Nanox’s vision is to expand the reach of medical imaging both within and beyond traditional hospital settings by providing a seamless solution from scan to interpretation and beyond. By leveraging proprietary digital X-ray technology, AI-driven analytics, and a clinically driven approach, Nanox aims to enhance the efficiency of routine imaging workflows, support early detection of disease, and improve patient outcomes.
The Nanox ecosystem includes Nanox.ARC, a cost-effective, 3D multi-source digital tomosynthesis imaging system designed for ease of use and scalability; Nanox.AI, a suite of AI-based algorithms that augment the interpretation of routine CT imaging to identify early signs often associated with chronic disease; Nanox.CLOUD, a cloud-based platform for secure data management, storage, and advanced imaging analytics; Nanox.MARKETPLACE and USARAD Holdings, which provide access to remote radiology and cardiology experts and comprehensive teleradiology services; and Nanox Health IT, which combines deep healthcare IT expertise with leading technology partners to deliver RIS, PACS, AI, dictation, and secure infrastructure solutions that streamline workflows and support safer, more efficient care delivery.
By integrating imaging technology, AI, cloud infrastructure, clinical expertise, a marketplace, and health information technology, Nanox seeks to lower barriers to adoption, improve utilization, and advance preventive care worldwide. For more information, please visit www.nanox.vision
Contacts
Investor Contact
Mike Cavanaugh
ICR Healthcare
mike.cavanaugh@icrhealthcare.com
Media Contact
ICR Healthcare
NanoxPR@icrinc.com
